Delcath media headlines

MarketWatch (press release) - May 21, 2012 NEW YORK, May 21, 2012 /PRNewswire via COMTEX/ -- Delcath Systems, Inc. (NASDAQ:DCTH) will host a live webcast of management's presentation to shareholders at the Company's annual stockholder meeting on May 23, 2012 at 10:00 am ET at The Michelangelo ...

Alkermes (NASDAQ:ALKS) Posts Loss 4Q on Elan Deal, Revenue Jumps- ALKS, VRX ... Junction Report - 18 hours ago By Abby Stone, Business, Editors Choice Alkermes Plc (NASDAQ:ALKS) reported on Thursday it took a bigger loss in its fiscal Q4 following it obtained a drug technology business and took a one-time charge associated to research and development.

MarketWatch (press release) - May 8, 2012 NEW YORK, May 8, 2012 /PRNewswire via COMTEX/ -- Delcath Systems (UTD:DCTH) today announced financial results and highlights for its first quarter 2012 ended March 31, 2012 and recent weeks.

Seeking Alpha - May 7, 2012 With its many setbacks due to systemic toxicities and side effects, chemotherapy remains the standard of care treatment for many cancers either as a first-line treatment or as an adjuvant.

Sacramento Bee - May 1, 2012 By Delcath Systems, Inc. NEW YORK, May 1, 2012 -- /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced that it will host a conference call and webcast on Tuesday, May 8, 2012 at 4:30 pm ET to provide an update on recent corporate progress and ...

Low Side Effects Seen in Treatment With Delcath's Second Generation ... MarketWatch (press release) - Apr 26, 2012 NEW YORK, April 26, 2012 /PRNewswire via COMTEX/ -- Delcath Systems, Inc. (UTD:DCTH) announced today that doctors from the European Institute of Oncology (Instituto Europeo di Oncologia - IEO) presented preliminary data showing reduced side effects in ... DELCATH SYSTEMS, INC. : Low Side Effects Seen in Treatment With Delcath's ... - 4-traders

Reuters Key Development - Apr 26, 2012

News-Medical.net - Apr 23, 2012 Delcath Systems, Inc. (NASDAQ: DCTH) today announced it has closed a $20 million working capital line of credit revolver with Silicon Valley Bank ("SVB"), a leading provider of banking services in the life sciences. Delcath Systems, Inc. Secures $20 Million Credit Facility - Benzinga

SYS-CON Media (press release) - Apr 23, 2012 By PR Newswire NEW YORK, April 23, 2012 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) today announced it has closed a $20 million working capital line of credit revolver with Silicon Valley Bank ("SVB"), a leading provider of banking services in ...

Reuters Key Development - Apr 23, 2012

DELCATH SYSTEMS, INC. : Delcath Announces First Patient Treatment Using Second ... 4-traders - Apr 13, 2012 NEW YORK, April 13, 2012 /PRNewswire via COMTEX/ --Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the first treatment using the second generation hemofiltration cartridge of the Company's proprietary Hepatic CHEMOSAT? Delivery System has ...

RTT News - Apr 13, 2012 (RTTNews) - Specialty pharmaceutical company Delcath Systems Inc (DCTH: News ) Friday revealed that the European Institute of Oncology, a premier cancer treatment and research center in Milan has performed the first treatment using the second ... Delcath Announces First Patient Treatment Using Second Generation ... - Sacramento Bee

Sacramento Bee - Apr 11, 2012 By Delcath Systems, Inc. NEW YORK, April 10, 2012 -- In the news release, Delcath Announces Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital for Training and Launch of Hepatic Chemosat Delivery System, issued 10-Apr-2012 by ...

Delcath Receives European Regulatory Approval for Second Generation ... Sacramento Bee - Apr 5, 2012 By Delcath Systems, Inc. NEW YORK, April 5, 2012 -- /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the Company has received CE Mark approval for the second generation hemofiltration cartridge of the Company's proprietary ... Delcath Says Hemofiltration Cartridge Gets CE Mark Approval - NASDAQ

RTT News - Apr 5, 2012 (RTTNews) - Oncology-based pharma and medical device company Delcath Systems, Inc. (DCTH: News ) announced the receipt of CE Mark approval for the second-generation hemofiltration cartridge of its proprietary Hepatic CHEMOSAT Delivery System, ... Delcath Receives European Regulatory Approval for Second Generation ... - African Business Review (press release)